Member briefing: The NICE guideline on the diagnosis and management on AMD includes recommendations for testing, and a comprehensive list of classifications to aid referral.
The clinical figures that count.
This article summarises the Cochrane reviews on nutritional supplementation in age-related macular degeneration (AMD).
Eye health issues that are making the news.
In the first of a three-part series, Helen Bird explores the importance of biomarkers in indicating disease, some of the latest OCT imaging biomarkers and how they relate to optometrists’ work.
Chris Steele FCOptom, new Clinical Editor of Acuity, on change as a positive factor
A glance at what’s happening in the world of technology.
Adrian O’Dowd examines the evidence for a link between sleep apnoea and AMD, which could help optometrists assess the risk of vision loss quicker and more accurately.
The four UK nations’ scopes of practice, pathways and eyecare initiatives are changing. Here’s how.
Increasing pressures on the NHS and patient-focused management mean interest in home monitoring of eye conditions has increased. Sophie Goodchild examines self-monitoring for wet AMD, the latest technology and what the future holds.
The number of people with glaucoma, AMD and cataracts is set to increase over the next 10 years. This new online tool will be a critical planning resource for commissioners and providers of eye health care.
Drusen can be a significant finding, but they aren’t always a harbinger of doom. With new approaches on the horizon, asks Kaye McIntosh, what should optometrists do when drusen are found?
Podcast: The College Clinical Advisers discuss ways to highlight the importance of regular sight tests as part of National Eye Health Week.
Podcast: College Clinical Adviser Denise Voon MCOptom and Mike Horler, Consultant Optometrist, answer your questions about age-related macular degeneration (AMD).
Clinical files: Can I prescribe medicines for intravitreal injection for the management of wet AMD patients?
Jane Veys MCOptom on reducing the tears and fears of our patients
Adrian O’Dowd explores a new treatment for late-stage dry AMD being considered for approved use in the UK that could raise hopes of delaying the irreversible sight loss caused by the disease.
Clinical files: What impact should a patient's home genetics test have on my clinical decision-making?
Clinical files: Do I have to refer an asymptomatic patient with a small pigment epithelial detachment (PED)?
Welcome to the UK's leading optometry conference - our flagship CPD event!
In the final part of our series on ageing, Adrian O’Dowd looks at how technology will play a vital role in eye care for older people.
Abstracts from the online Women in Vision UK Annual Meeting 2022 are presented.